Kineta, Inc. (KA) stock declined over -30.77%, trading at $0.57 on NASDAQ, down from the previous close of $0.83. The stock opened at $0.78, fluctuating between $0.56 and $0.83 in the recent session.
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
Employees | 11 |
Beta | 0.57 |
Sales or Revenue | $5.44M |
5Y Sales Change% | -0.952% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Kineta, Inc. (NASDAQ: KA) stock price is $0.57 in the last trading session. During the trading session, KA stock reached the peak price of $0.83 while $0.56 was the lowest point it dropped to. The percentage change in KA stock occurred in the recent session was -30.77% while the dollar amount for the price change in KA stock was -$0.26.
The NASDAQ listed KA is part of Biotechnology industry that operates in the broader Healthcare sector. Kineta, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Pauline Kenny J.D.
Gen. Counsel
Dr. Shawn P. Iadonato Ph.D.
Chair of the Board & Chief Executive Officer
Mr. Craig W. Philips
Pres
Ms. Molly Dorr
Head of HR & Operations
Dr. Thierry Guillaudeux Ph.D.
Chief Scientific Officer
Mr. Jacques Bouchy
Executive Vice President of Investor Relations & Bus. Devel.
Mr. Kenneth R. North
Senior Vice President of Corporation Devel.
Mr. Keith Baker
Chief Financial Officer
Mr. Keith A. Baker
Chief Financial Officer
Ms. Pauline Kenny Esq., J.D.
Gen. Counsel & Sec.
KA's closing price is 72.09% higher than its 52-week low of $0.33 where as its distance from 52-week high of $5.39 is -89.34%.
Number of KA employees currently stands at 11.
Official Website of KA is: https://kinetabio.com
KA could be contacted at phone 206 378 0400 and can also be accessed through its website. KA operates from 219 Terry Ave. N, Seattle, WA 98109, United States.
KA stock volume for the day was 480.68K shares. The average number of KA shares traded daily for last 3 months was 504.1K.
The market value of KA currently stands at $7.05M with its latest stock price at $0.57 and 12.26M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com